Stanniocalcin 1 (STC1) is a hypocalcemic hormone that is known to play an important role in calcium metabolism in teleost fish. An increase in blood Ca 2C levels stimulates its synthesis and release. . Our results indicated that STC1 exerted its inhibitory action via a cAMP pathway to lower intracellular Ca 2C levels.
. Our results indicated that STC1 exerted its inhibitory action via a cAMP pathway to lower intracellular Ca 2C levels.
Intriguingly, we were able to block the action of STC1 using an inhibitor, NS-398, of cyclooxygenase-2 (COX-2), which is known to stimulate the activity of sarcoplasmic and endoplasmic reticulum Ca 2C -ATPase (SERCA). A follow-up experiment in which gill cells were incubated with STC1 revealed a downregulation of the epithelial Ca 2C channel (ecacl) but an
Introduction
The fish gill is a multifunctional transport epithelium that simultaneously participates in an assortment of ion and molecule transport activities, including the transport of respiratory gases, universal osmolytes, nitrogenous waste, and water (Evans et al. 2005) . The gill is critical to the regulation of ionic and osmotic homeostasis in fish and thus plays a large role in osmotic adaptability. A number of key hormones (growth hormone, cortisol, prolactin, natriuretic peptides, and stanniocalcin 1 (STC1)) have been identified that are essential in coordinating gill activity. Over the past decade, a considerable number of studies have investigated how ion-osmoregulatory function associates with changes in plasma hormone levels and with the regulation of the expression of different ion transporters/channels in gill cells (Perry 1997 , Wong & Chan 1999a ,b, Evans 2002 , Evans et al. 2005 , Tse et al. 2006 . Different models of ion transport in gill cells of both freshwater (FW) and seawater fish and the functional roles of the respective hormones have been proposed and summarized in recent reviews (Hwang et al. 2011 , Takei et al. 2014 . The results of these studies provide unequivocal evidence that strengthens our understanding of fish ion-osmoregulation. Among different ion-regulatory hormones, the glycoprotein STC1 plays an important role in plasma Ca 2C homeostasis in fish, but the underlying mechanisms of its post-receptor signaling pathways and their effects on gill cells remain mostly unknown. STC1 is a glycosylated hypocalcemic hormone synthesized from a unique endocrine gland, the corpuscle of Stannis (CS), in bony fish (Wagner et al. 1986) . A rise in serum Ca 2C levels stimulates STC1 release from the CS.
STC1 reduces branchial and intestinal Ca 2C uptake but stimulates renal Pi reabsorption (Gerritsen & Wagner 2005) . The STC1 paralog STC2 has been cloned in fish (Luo et al. 2005 , Shin & Sohn 2009 ; it is, however, widely expressed in multiple tissues, and its function in fish is largely still not known. Yet the biological action of STC1 in inhibiting gill Ca 2C transport (GCAT) has been generally applied as a standard bioassay to test the hypocalcemic potency of CS extracts or recombinant STC1 proteins (Wagner et al. 1986 , 1993 , Olsen et al. 1996 . Although this is the most recognized action of STC1, major gaps still exist in our knowledge of the mechanism behind the inhibition of GCAT by STC1. The identification of STC1 target cells is hindered by the lack of information on STC1 receptors. Although an STC1 receptor has not been cloned yet, indirect evidence indicates that STC1 receptors belong to the family of G-protein-coupled receptors (Lu et al. 1994) .
Using isolated flounder proximal tubules, Lu et al. (1994) showed that STC1 treatment stimulated a PKA-dependent pathway via an elevation of cellular cAMP levels. This observation provided a hint for investigating the STC1-mediated signaling cascade and possible downstream targets in Ca 2C -transporting tissues.
Plasma Ca 2C concentration affects STC1 secretion from CS glands and thus the rate of GCAT. We proposed the hypothesis that in fish adapted to water with varying Ca 2C content, GCAT is also regulated by alteration of the expression of branchial STC1 receptors in response to STC1. To address this hypothesis, we aimed to elucidate the mechanism of STC1 binding and signaling in the fish gill. Our data indicated that branchial STC1 binding sites were significantly more numerous in the plasma membrane and were increased in fish acclimated in high-Ca
2C
FW. The binding of STC1 stimulated cAMP signaling in both pavement cells (PVCs) and mitochondria-rich cells (MRC) to stimulate the expression of epithelial calcium channel (ecacl) and cyclooxygenase-2 (cox-2) to regulate Ca 2C homeostasis.
Materials and methods

Animals, gill cells, and CS gland isolation
Japanese eels (Anguilla japonica), weighing between 500 and 600 g, were reared in fiberglass tanks supplied with charcoal-filtered, aerated tap water at 18-20 8C. They were placed under a 12 h light:12 h darkness cycle for acclimation before experiments were performed. The fish were then divided into two groups: low-Ca 2C FW (local tap water, 0.2 mM Ca 2C ) and high-Ca 2C FW (local tap water with added CaSO 4 , 2 mM Ca 2C ). After 14 days, the fish were sampled and killed by anesthesia in tap water containing 0.1% MS-222 (Sigma). Gills were perfused with PBS (pH 7.7), and gill arches were excised, washed, and cut into small fragments for enzymatic digestion. After cell dissociation, resuspended gill cells were layered on a two-step Percoll gradient system (1.03 and 1.09 g/ml in PBS) and centrifuged (2000 g) at 15 8C for 20 min. The isolated gill cells at the interface of 1.03 and 1.09 g/ml were collected and washed with PBS, followed by Hank's balanced salts solution (HBSS, Gibco). In some experiments, a three-step Percoll gradient (1.03/1.06/1.09 g/ml) was used for the isolation of specific cell types, specifically PVCs and MRCs, as described in our previous study (Wong & Chan 1999b) . The isolated gill cells were incubated at 22 8C for 1-2 h before experiments. CS glands of the fish were also collected and dissected for subsequent experiments.
Expression constructs for eel STC1 fusion proteins STC1-V5 and STC1-alkaline phosphatase (AP) fusion proteins were generated by cloning the PCR-amplified, in-frame coding region of eel STC1 into pENTRTM/SD/ D-TOPO (Invitrogen) and pAPtag-5 vectors (GenHunter, Nashville, TN, USA), both according to the manufacturers' instructions. STC1 inserts were verified by DNA sequencing. STC1-V5 or STC1-AP expression vectors were transfected into the human embryonic kidney cell line (293FT) using Lipofectamine 2000 reagent (Invitrogen). The vectors without the insert (V5 alone or AP alone) were also transfected into 293FT cells as negative controls. Conditioned media were collected and concentrated 20-fold using Vivaspin 20 concentrators (GE Healthcare Life Sciences, Pittsburgh, PA, USA). The expression levels of STC1-fusion proteins were checked by western blotting. The concentrations of STC1-fusion proteins were determined by an ELISA using the DuoSet ELISA Kit (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's instructions. Briefly, the high-binding, flat-bottomed polypropylene microplates were coated with goat anti-human STC1 antibody at room temperature overnight; they were then washed with PBS containing 0.05% Tween-20 (PBST) and blocked with the reagent diluent (PBS containing 1% BSA, R&D Systems) for 1 h. Either samples or diluted STC1 standard (62.5-4000 pg/ml) were added to the antibody-coated wells for 2 h. The samples or standard were then washed with PBST and incubated with the biotinylated goat anti-human STC1 antibody for 2 h. After the addition of tetramethylbenzidine substrate (R&D Systems), the reaction was stopped with Stop Solution (1 M H 2 SO 4 ). The absorbance at 450 nm was determined for each well using a microplate reader (Bio-Tek (Winooski, VT, USA), ELX800).
Measurement of cAMP levels
Isolated gill cells were incubated with i) CS extracts, 1 mg of total protein (collected from fish adapted to low-or highCa 2C FW), ii) 0.5 nM STC1-V5, or iii) V5 alone in HBSS for 45 min. To verify if any observed effects were from endogenous STC1 in the CS extracts, we repeated the experiment with a pre-incubation period using goat anti-STC1 antibody (R&D Systems 
In situ ligand binding assays
To localize STC1 binding sites at the histological level, in situ ligand binding was performed using STC1-AP, as previously described (McCudden et al. 2002 , Wu et al. 2006 . Paraformaldehyde-fixed gill tissues were de-waxed, rehydrated in graded ethanol, and rinsed in PBST containing 0.1% Tween 20. The experimental procedure involved pretreating the tissue sections with 3% normal goat serum in PBST to reduce nonspecific binding, then incubating them overnight at 4 8C with: i) V5 alone, ii) 0.5 nM STC1-V5, or iii) 0.5 nM STC1-V5 plus 50 nM STC1-AP (for competitive binding). The slides were incubated at room temperature with mouse antiNa C /K C -ATPase-subunits (1:200; Naa5, Developmental Studies Hybridoma Bank, University of Iowa) for 1 h, and then incubated with a cocktail of Alexa Fluor 568 goat antimouse IgG (1:200; Life Technologies) and anti-V5-FITC (1:500; Life Technologies). The slides were washed three times for 15 min in PBST after each antiserum application. Nuclei were stained with DAPI mounting medium (Vector Laboratories, Burlingame, CA, USA). The localization of ECaCl was determined in gill sections exposed to rabbit anti-ECaCl (1:40; Abcam, New Territories, Hong Kong, China), and then incubated for 1 h with Alexa Fluor 488 goat anti-rabbit IgG (1:200). The slides were examined using an EVOS FLoid Cell Imaging Station (Life Technologies).
STC1 receptor-binding assay
An STC1 receptor-binding assay was conducted using nuclear, mitochondrial, and plasma membrane fractions of gill cells. Cell fractionation was performed and verified following methods described previously (McCudden et al. 2002) . Briefly, gill cells were Dounce-homogenized in 1 ml of 0.1 M Tris-HCl (pH 7.6) containing 0.25 M sucrose and 5 mM EDTA. The homogenate was then centrifuged twice at 1000 g for 15 min, once at 15 000 g for 30 min, and finally at 100 000 g for 90 min, which thereby isolated crude nuclear, mitochondrial, and plasma membrane fractions respectively. The isolated subcellular fractions were then resuspended in 50 mM HEPES (pH 7.6) and protein concentrations were quantified. Samples were stored at K80 8C.
For the binding assay, 2.5 mg aliquots of each subcellular fraction were incubated in i) AP alone, ii) 0.5 nM STC1-AP, or iii) 0.5 nM STC1-AP plus 50 nM STC1-V5 (for competitive binding) in HBSS containing 0.1% BSA (HBHA; pH 7.5) using an orbital shaker (20 r.p.m., 3D/fixed 20 8C) for 2 h. To separate bound and free STC-AP ligands, samples were centrifuged for 3 min at 10 000 g to pellet the protein and then washed twice in 1 ml of ice-cold HBHA. The pellets were then solubilized in 15 ml of 1% Triton X-100 in 10 mM Tris-HCl, (pH 8.0) to detect AP activity. Specific binding was determined by subtracting AP activity in the negative controls (AP alone) from AP activity in samples incubated with STC1-AP. To examine the specific activity of the STC1-AP ligand, data were converted into units of STC1 for the calculation of K d and B max using GraphPad Prism (LaJolla, CA, USA).
AP activity was measured using the Phospha-Light SEAP Reporter Gene Assay System for the detection of placental AP activity, according to the manufacturer's instructions (Novex, Life Technologies). Briefly, samples that had been mixed with a dilution buffer (1:1) were heated at 65 8C for 30 min, and then cooled to room temperature. An aliquot (25 ml) of the sample mix was then incubated with 25 ml of assay buffer, and then 25 ml or reaction buffer at room temperature were added. Luminescence was measured using the VICTOR X4 Multilabel Plate Reader (PerkinElmer Life Sciences).
Ratiometric digital imaging of [Ca 2C ] i
Gill cells were seeded on collagen-coated (50 mg/ml, Cultrex, Gaithersburg, MD, USA), round (25 mm) glass coverslips with a density of 2!10 5 cells/coverslip. Slides were maintained in a phenol-red-free HBSS medium that was supplemented with 10% fetal bovine serum in a 22 8C humidified chamber. The cells were then incubated with 1 mM Fura-2/AM in HBSS medium for 2 h at 22 8C. After dye loading, the cells were washed twice, also with HBSS medium, and the coverslips were then secured in a small chamber containing 500 ml of the medium. Gill cells were treated with i) thapsigargin (TG) (2 mM, Calbiochem, San Diego, CA, USA), ii) a co-treatment of TG with 0.5 nM STC1-V5 or V5, or iii) a pretreatment with inhibitors (i.e. PKA inhibitor (100 nM 14-22 Amide, Calbiochem) or COX-2 inhibitor (2 mM NS-398, Cayman, Ann Arbor, MI, USA)). The cells were imaged using an inverted microscope (Nikon) equipped with a CCD camera (CoolSnap HQ, Tucson, AZ, USA). Cell images were captured with excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm. Images were analyzed using the MetaFluor Software (Sunnyvale, CA, USA). Images containing 30-40 cells were selected, and an excitation ratio for wavelengths of 340:380 nm was recorded.
LDH activity analysis
Isolated gill cells were incubated in 200 ml HBSS medium for 4 h with the following: i) 2 mM TG (Calbiochem), ii) a co-treatment of TG with 0.5 nM STC1-V5 or V5 alone, or iii) a co-treatment of TG with 0.5 nM STC1-V5 or V5 alone, plus either a PKA inhibitor (100 nM 14-22 Amide, Calbiochem) or a COX-2 inhibitor (2 mM NS-398, Cayman). After incubation, supernatants were collected for measuring LDH activity with an LDH Cytotoxicity Assay Kit (Cayman), according to the manufacturer's instructions. Absorbance signals were detected at 490 nm using a microplate reader (Bio-Tek, ELX800).
Real-time PCR analysis
Isolated gill cells in HBSS medium were treated with i) V5 alone, ii) 0.5 nM STC1-V5, or iii) 2 mM TG for 4 h at 22 8C. In some treatments, the cells were pre-incubated for 5 min with the PKA inhibitor (100 nM 14-22 Amide, Calbiochem). Purified RNA with a ratio of 1.8:2.0 for A260:A280 was used. Briefly, 0.5 mg of total cellular RNA was reverse transcribed using a high-capacity RNA-to-cDNA Kit (Applied Biosystems). PCRs were conducted with the StepOne realtime PCR system using the power SYBR Green PCR master mix (Applied Biosystems). Verified gene-specific primers for Japanese eels were used (gapdh-F: GCGCCAGCCAGAACAT-CATC, gapdh-R: CGTTAAGCTCGGGGATGACC; STC1-F: CTCAGAGGTTCAGGAGGAGT, STC1-R: GGTGCTGTAG-TACCTGTTGG; cox-2-F: TAGCCCACCAACCTACAATG, cox-2-R: TGAGCAAAAAAGGCAAACAC; and ecacl-F: GCAGCCCAATAAAACCATCGC, ecacl-R: CCACCACATTG-CCCTCCTG). We referenced parallel amplifications of the cloned PCR fragments with known concentrations to calculate the copy number of transcripts for each sample. We tested for the occurrence of primer-dimers and secondary products using melting curve analysis. Our results indicated that the amplification was specific for each individual set of primers. Control amplification was done either without reverse transcriptase or without RNA. The relative expression ratio of a target gene ((STC1, cox-2, or ecacl)/gapdh) was calculated according to a previously described method (Pfaffl 2001) : Expression ratioZE target CPtarget (control-treatment) /E gapdh CPgapdh (control-treatment) ,
Western blot analysis
Protein lysates were subjected to electrophoresis in 8% polyacrylamide gels. Lysates contained 20-40 mg of total protein in a radioimmunoprecipitation assay buffer mixed with 5! SDS loading buffer (250 mM Tris-HCl at pH 6.8, 10% SDS, 50% glycerol, 5% b-mercaptoethanol, 62.5 mM EDTA, and 0.1% bromophenol blue). Postelectrophoresis, the gels were blotted onto PVDF membranes (PerkinElmer Life Sciences). Western blotting was conducted using rabbit antibodies against STC1 (Origene, Rockville, MD, USA) and AP (GenHunter) as well as mouse antibodies against V5 (Invitrogen) and His (GE Healthcare Life Science), and then the gels were incubated with HRP-conjugated goat anti-rabbit or antimouse antibody (1:4000; Bio-Rad). Specific bands were visualized using a chemiluminescent reagent (WesternLightening Plus, PerkinElmer Life Sciences). For some experiments, the blots were then washed in PBST and re-probed with mouse monoclonal anti-fish actin antibody (1:100; JLA20, Developmental Studies Hybridoma Bank).
Statistical analysis
Drug treatments were performed in triplicate for each experiment, and every experiment was repeated at least three times. All data are represented as meansGS.E.M. Statistical significance was assessed with Student's t-test or one-way ANOVA, followed by Duncan's multiple range tests. Groups were considered significantly different if P!0.05.
Results
Effects of CS extracts on the production of cAMP in gill cell cultures
The CS extracts from eels adapted to low-or high-Ca 2C FW
conditions were used to test their effects on cAMP production in gill cell cultures. Both real-time PCR and western blot analysis revealed greater STC1 expression in the CS extracts from fish adapted to high-Ca 2C FW (Fig. 1A) . The results of ELISA analysis indicated that the STC1 content in CS extracts from fish adapted to low-and high-Ca 2C FW were 8.2G1.27 and 62.3G4.53 pmol/mg protein respectively (Fig. 1A) . CS extracts from both groups of eels significantly induced increases in the cAMP levels in the gill cells (Fig. 1B) . However, the effect of the CS extract from fish adapted to high-Ca 2C FW was significantly greater. To test if our results were indeed caused by the presence of STC1, rather than other compounds in the extracts, we conducted an antibody-neutralizing experiment against STC1. The use of STC1 antibody abolished the effects of the extracts (Fig. 1C) .
The binding of the STC1 recombinant protein on paraffin-embedded gill tissues of fish adapted to low-and high-Ca 2C FW
To verify if the STC1 recombinant protein (STC1-V5) was biologically active, the cAMP production assay was conducted using gill cell cultures. The presence of the recombinant protein in the conditioned medium of STC1-V5-transfected 293FT cells was verified using an antibody against STC1 or V5 ( Fig. 2A) . The treatment of gill cell cultures with the recombinant protein STC1-V5 stimulated an elevation of cytosolic cAMP levels. The stimulatory effect was abolished when the cultures were co-treated with the STC1 neutralizing antibody (Fig. 2B) .
To determine the spatial expression profile of STC1 receptors, an STC1-V5 binding assay was conducted. As shown in Fig. 2C , binding was detected on both gill PVCs and MRCs at the lamellar and inter-lamellar regions (Fig. 2C, ii and v) . A significant increase in STC1-V5 binding was detected in the gill sections prepared from fish adapted to high-Ca 2C FW (Fig. 2C, v) . The spatial localization of the STC1-V5 binding sites indicated that the expression of STC1 receptors was not restricted to a specific epithelial cell type. To validate this observation, we conducted cAMP assays using gill PVCs and MRCs isolated by three-step Percoll-gradient centrifugation. Both cell types responded to STC1-V5 with significant inductions of cAMP levels (Fig. 2D ).
The binding of the STC1 recombinant protein (STC1-AP) to subcellular fractions of gill preparations
The recombinant protein STC1-AP was prepared and verified with western blotting using antibodies against AP, His, or STC1 (Fig. 3A) . The saturation binding assays were carried out on isolated gill nuclear, mitochondrial, and plasma membrane preparations, and they detected high-affinity and high-capacity binding sites in all three preparations. Figure 3B shows the saturation binding data of STC1-AP and AP on the isolated gill plasma membrane preparations from the low-Ca 2C and the high-Ca 2C conditions. The binding data for mitochondrial and nuclear preparations are shown in Supplementary Fig. 1 , see section on supplementary data given at the end of this article. The specific STC1-AP binding values (K d and B max ) were then calculated for each of the individual subcellular preparations ( Fig. 3C and D) . Under the low-Ca (Fig. 3D ). There were no significant changes in the K d of all the subcellular preparations obtained under high-or low-Ca 2C conditions. However, a significant increase in B max was identified in the plasma membrane preparations from eels exposed to high-Ca 2C conditions. Levels of nonspecific binding were similar among the samples. Using STC1-V5 it was possible to display the binding of STC1-AP.
Effects of STC1-V5 on intracellular Ca 2C levels, expression of ecacl and cox-2
In this part of the present study, we used TG to induce an increase in cytosolic Ca 2C , which allowed us to test for the inhibitory effect of STC1 using the recombinant protein STC1-V5 as the ligand. TG treatment induced an increase in intracellular Ca 2C [Ca 2C ] i (Fig. 4A, i ). The addition of V5 (Fig. 4A , ii and iii) or STC1-V5 alone (Fig. 4A, iv) (Fig. 4A, v) . The co-treatment with the PKA inhibitor (PKAi, 14-22 Amide) or the COX-2 inhibitor (NS-398) significantly reduced the effect of STC1-V5, whereas the inhibitor alone had no noticeable effects (Fig. 4A , vi, vii, viii and ix).
To address the functional outcome of STC1's effects on the TG-induced increase in cytosolic Ca 2C , a cytotoxicity assay was conducted. STC1 significantly reduced TG-induced cytotoxicity (Fig. 4B) . Additionally, cotreatment with the inhibitors significantly reduced the protective effect of STC1. The gill tissues of fish adapted to low-Ca 2C FW or high-Ca 2C FW expressed ECaCl ( Supplementary Fig. 2 , see section on supplementary data given at the end of this article). To elucidate the effects of STC1-V5 on the downstream targets associated with Ca 2C regulation, the expression levels of ecacl and cox-2 were measured. STC1-V5 treatment significantly increased cox-2 but reduced ecacl mRNA expression levels ( Fig. 5A and B) . The addition of PKAi abolished the action of STC1-V5.
Discussion
The results of the present study indicated a possible mechanism for STC1 inhibition of GCAT, using various preparations of STC1 receptor ligands (CS extracts, recombinant STC1 proteins) and bioassays (cAMP, in situ ligand binding, receptor binding). Our results support the hypothesis that functional STC1 receptors are present in gill cells. In response to STC1 binding, the expression level of the downstream target, ecacl, was modulated to reduce GCAT in order to regulate systemic Ca 2C levels. Results of previous research have indicated that STC1 treatment elevates cellular cAMP levels in flounder proximal tubules and thereby stimulates a PKA-dependent pathway (Lu et al. 1994) . However, as far as we are aware, no prior study exists that tests the signaling pathway of STC1 using fish gills, one of the hormone's major tissue targets. In the present study, we therefore adopted the gill cell culture model to validate the effect of STC1 on cAMP levels. Our results indicated clearly that there was a significant upregulation of cAMP in gill cells upon treatment with CS extracts. Specifically, we demonstrated that a significantly greater stimulation of cAMP production occurred when CS extracts of fish adapted to high-Ca 2C rather than low-Ca 2C FW conditions were used. This result is primarily an effect of the greater amount of STC1 synthesized and stored in the glands of fish adapted to high-Ca 2C FW. We also ruled out possible effects from other proteins in the CS extracts via the application of a neutralizing antibody, which confirmed the specific action of STC1. Moreover, the use of the STC1 recombinant protein STC1-V5 resulted in a similar effect on the stimulation of cAMP production in gill cell cultures. Taken together, this part of study indicated that STC1-signaling was mediated by cAMP, which supported the results of previous studies.
Next, we showed that environmental/plasma Ca 2C levels affect changes to STC1 binding sites in fish gills. To our knowledge, the present study is the first to expressly demonstrate a connection between these two factors in this particular tissue. Specifically, the results of our in situ ligand binding assay clearly revealed a significant increase in STC1 binding sites in the gills of fish adapted to highCa 2C as opposed to low-Ca 2C FW. In addition, the results of the receptor-binding assay that used subcellular fractions demonstrated specific binding of STC1 to plasma membrane, mitochondrial, and nuclear preparations. The estimated K d of all the subcellular preparations of gills ranged from 0.36 to 0.71 nM, which is similar to the K d from a STC1 receptor-binding study that used mammalian kidney and liver tissues (0.25-0.8 nM) (McCudden et al. 2002) , but they were tenfold lower than those of a study that used adipocyte membranes (7.9 nM) (Paciga et al. 2005) . Our results indicated that both plasma membrane and mitochondrial preparations showed greater binding affinities to STC1 than nuclear preparation did. More specifically, the significant increase in B max in the gill plasma membranes from fish adapted to high-Ca 2C FW might indicate an increased expression of STC1 receptors in these cells. This observation supports the hypothesis that the expression levels of branchial STC1 receptors were altered in response to increased water or plasma Ca 2C content. In terms of the specific cells that express STC1 receptors, gill chloride cells (CCs/MRCs) have long been suggested to be the targets of STC1. However, to our knowledge, very few studies exist that have definitively demonstrated this, and what little data are available are indirect (Flik & Verbost 1993 , Chan & Wong 1997 . In the present study, the increase in STC1 binding was observed across both the lamellar and inter-lamellar regions of the gill sections. Furthermore, we found that both PVCs and MRCs responded to STC1 stimulation with elevated cytosolic cAMP levels. This result indicated that both gill PVC and MRC expressed STC1 receptors.
Finally, our results give further insight into the underlying mechanism behind the STC1 inhibition of GCAT and add to a small body of work that addresses this gap in our understanding. Results of previous research have indicated that CS extracts stimulate plasma membrane Ca 2C -ATPase in rainbow trout gills (Ma & Copp 1978) and, furthermore, that downregulation of STC1 in zebrafish embryos caused upregulation of ecacl expression (Tseng et al. 2009 (Thastrup et al. 1990) . In this study, STC1 functioned to reduce the TG-induced elevation of cytosolic Ca 2C levels, which was found to be mediated by cAMP. Intriguingly, using an inhibitor, NS-398, of COX-2, a prostaglandin-endoperoxide synthase known to stimulate the activity of SERCA, it was possible to block the action of STC1. The study revealed that COX-2 may be a possible downstream target of STC1, and this observation was supported by a follow-up experiment that indicated that STC1 induced upregulation of COX-2 expression in the gill cells. Moreover, STC1 treatment also inhibited ecacl expression. Because ECaCl is an important Ca 2C gatekeeper, ecacl inhibition may be one mechanism by which STC1 regulates systemic Ca 2C levels. Our findings in this regard mirror previous results for the zebrafish embryo (Tseng et al. 2009 ).
Overall, the present study builds on existing knowledge that STC1 acts on gills to inhibit GCAT by offering a mechanism for this action. The study provides direct evidence of STC1 binding, signaling, and mechanistic action in fish gills. Both gill PVCs and MRCs expressed STC1 receptors, which mediate cAMP signaling to regulate the expression of ECaCl and COX-2. In turn, the gatekeeper proteins reduce GCAT to regulate systemic Ca 2C levels. The results of our previous study revealed the role of gill Ca 2C -sensing receptor (CaSR) in stimulating the expression of STC1 in gill cells (Gu et al. 2014 ). More recently, Lin et al. (2014) reported the function of CaSR in regulating the expression of the hypercalcemic hormone parathyroid hormone 1 (PTH1) and STC1 using a zebrafish model. Both PTH1 and STC1 have been demonstrated to modulate the expression of ECaCl in affecting systemic Ca 2C homeostasis, presumably via a cAMP pathway.
Further investigations of the possible counterbalancing mechanism of STC1/PTH1 toward GCAT are warranted. Effects of STC1-V5 treatment on the expression levels of cyclooxygenase-2 (cox-2) and epithelial Ca 2C channel (ecacl) in gill cells. (A) The expression levels of cox-2 mRNA in gill cells were determined using real-time PCR. A significant upregulation of cox-2 expression upon STC1-V5 treatment was detected. Co-treatment with the inhibitor PKAi reduced the upregulation. (B) Effects of STC1-V5 treatment on the mRNA expression levels of ecacl in gill cells. A significant reduction of ecacl was noted upon STC1-V5 treatment, whereas PKAi co-treatment reduced the effects. Bars with the same letter are not significantly different according to the results of one-way ANOVA followed by Duncan's multiple tests (P!0.05).
